| (CNY) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 810.48M | 51.80% |
| Operating expense | — | — |
| Net income | -162.95M | 18.22% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 688266.SS returned +18.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +38.8% |
| 1 year | +18.0% |
| 5 years | +81.3% |
| All-time high | ¥128.71 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 688266.SS would be worth today ›No. Suzhou Zelgen Biopharmaceuticals Co., Ltd. has not paid a dividend in the past 12 months.
Suzhou Zelgen Biopharmaceuticals Co., Ltd. is part of the Healthcare sector.
Suzhou Zelgen Biopharmaceuticals Co., Ltd. has a market cap of 31.19B CNY, based on the latest quote.
